rs35372714

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014244.5(ADAMTS2):​c.1993G>A​(p.Gly665Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0131 in 1,613,422 control chromosomes in the GnomAD database, including 187 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0088 ( 11 hom., cov: 32)
Exomes 𝑓: 0.014 ( 176 hom. )

Consequence

ADAMTS2
NM_014244.5 missense

Scores

1
4
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.13
Variant links:
Genes affected
ADAMTS2 (HGNC:218): (ADAM metallopeptidase with thrombospondin type 1 motif 2) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The encoded preproprotein is proteolytically processed to generate the mature procollagen N-proteinase. This proteinase excises the N-propeptide of the fibrillar procollagens types I-III and type V. Mutations in this gene cause Ehlers-Danlos syndrome type VIIC, a recessively inherited connective-tissue disorder. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0048826337).
BP6
Variant 5-179136001-C-T is Benign according to our data. Variant chr5-179136001-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 384810.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr5-179136001-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00877 (1335/152254) while in subpopulation NFE AF= 0.015 (1022/68018). AF 95% confidence interval is 0.0143. There are 11 homozygotes in gnomad4. There are 600 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAMTS2NM_014244.5 linkc.1993G>A p.Gly665Arg missense_variant Exon 13 of 22 ENST00000251582.12 NP_055059.2 O95450-1
ADAMTS2XM_047417895.1 linkc.1498G>A p.Gly500Arg missense_variant Exon 12 of 21 XP_047273851.1
ADAMTS2XM_047417896.1 linkc.1111G>A p.Gly371Arg missense_variant Exon 11 of 20 XP_047273852.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAMTS2ENST00000251582.12 linkc.1993G>A p.Gly665Arg missense_variant Exon 13 of 22 1 NM_014244.5 ENSP00000251582.7 O95450-1
ADAMTS2ENST00000518335.3 linkc.1993G>A p.Gly665Arg missense_variant Exon 13 of 21 3 ENSP00000489888.2 A0A1B0GTY3
ADAMTS2ENST00000698889.1 linkn.1993G>A non_coding_transcript_exon_variant Exon 13 of 21 ENSP00000514008.1 A0A8V8TMU7

Frequencies

GnomAD3 genomes
AF:
0.00878
AC:
1335
AN:
152136
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00265
Gnomad AMI
AF:
0.0197
Gnomad AMR
AF:
0.00458
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00135
Gnomad SAS
AF:
0.00249
Gnomad FIN
AF:
0.00782
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0150
Gnomad OTH
AF:
0.00478
GnomAD3 exomes
AF:
0.00779
AC:
1958
AN:
251246
Hom.:
21
AF XY:
0.00753
AC XY:
1023
AN XY:
135886
show subpopulations
Gnomad AFR exome
AF:
0.00228
Gnomad AMR exome
AF:
0.00396
Gnomad ASJ exome
AF:
0.000596
Gnomad EAS exome
AF:
0.00120
Gnomad SAS exome
AF:
0.00304
Gnomad FIN exome
AF:
0.00906
Gnomad NFE exome
AF:
0.0125
Gnomad OTH exome
AF:
0.00799
GnomAD4 exome
AF:
0.0135
AC:
19739
AN:
1461168
Hom.:
176
Cov.:
34
AF XY:
0.0132
AC XY:
9598
AN XY:
726886
show subpopulations
Gnomad4 AFR exome
AF:
0.00209
Gnomad4 AMR exome
AF:
0.00398
Gnomad4 ASJ exome
AF:
0.000803
Gnomad4 EAS exome
AF:
0.00106
Gnomad4 SAS exome
AF:
0.00294
Gnomad4 FIN exome
AF:
0.00857
Gnomad4 NFE exome
AF:
0.0162
Gnomad4 OTH exome
AF:
0.0113
GnomAD4 genome
AF:
0.00877
AC:
1335
AN:
152254
Hom.:
11
Cov.:
32
AF XY:
0.00806
AC XY:
600
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.00265
Gnomad4 AMR
AF:
0.00458
Gnomad4 ASJ
AF:
0.000865
Gnomad4 EAS
AF:
0.00136
Gnomad4 SAS
AF:
0.00249
Gnomad4 FIN
AF:
0.00782
Gnomad4 NFE
AF:
0.0150
Gnomad4 OTH
AF:
0.00473
Alfa
AF:
0.0115
Hom.:
19
Bravo
AF:
0.00776
TwinsUK
AF:
0.0148
AC:
55
ALSPAC
AF:
0.0171
AC:
66
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.0142
AC:
122
ExAC
AF:
0.00785
AC:
953
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0123
EpiControl
AF:
0.0130

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

ADAMTS2: BS1, BS2 -

May 30, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 26, 2018
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 27377421) -

Ehlers-Danlos syndrome, dermatosparaxis type Benign:3
Dec 09, 2019
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
Jan 11, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: ADAMTS2 c.1993G>A (p.Gly665Arg) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0078 in 251246 control chromosomes in the gnomAD database, including 21 homozygotes. The observed variant frequency is approximately 3 fold of the estimated maximal expected allele frequency for a pathogenic variant in ADAMTS2 causing Ehlers-Danlos Syndrome, Type VIIC (Dermatosparaxis) phenotype (0.0029), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.1993G>A in individuals affected with Ehlers-Danlos Syndrome, Type VIIC (Dermatosparaxis) and no experimental evidence demonstrating its impact on protein function have been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -

Ehlers-Danlos syndrome Benign:1
Apr 28, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.79
D;.
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.097
FATHMM_MKL
Benign
0.56
D
MetaRNN
Benign
0.0049
T;T
MetaSVM
Benign
-0.65
T
MutationAssessor
Uncertain
2.2
M;.
PrimateAI
Uncertain
0.56
T
PROVEAN
Pathogenic
-5.5
D;.
REVEL
Benign
0.12
Sift
Benign
0.059
T;.
Sift4G
Benign
0.14
T;.
Polyphen
0.24
B;.
Vest4
0.33
MutPred
0.25
Gain of MoRF binding (P = 0.0138);Gain of MoRF binding (P = 0.0138);
MVP
0.37
MPC
0.50
ClinPred
0.060
T
GERP RS
4.5
Varity_R
0.24
gMVP
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs35372714; hg19: chr5-178563002; COSMIC: COSV99078629; API